IEX vs ZYME · P/E 29, rev $1.81B vs rev $106.0M
IDEX Corporation (IEX) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
IDEX Corporation (IEX) is a specialty industrial machinery company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported IEX revenue for 2026-06-30 was $1.81B. Net income was $263.4M. IEX currently screens at market cap $13.71B and trailing P/E 28.8.
Latest reported ZYME revenue for 2025-12-31 was $106.0M. Net income was -$81.1M. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. ZYME currently screens at market cap $1.68B.
IEX currently screens at market cap $13.71B and trailing P/E 28.8. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the IEX and ZYME stock pages for the full models.
Not investment advice.